
Keywords: Bisbenzimidazole derivatives; Specific inhibitors of the trypsin-like sites; Constitutive proteasome; Immunoproteasome; In silico docking; c20S; 20S constitutive proteasome catalytic core; cChT-L (β5c subunit); chymotrypsin-like; cT-L (β2c subunit); try